Literature DB >> 7741548

Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.

L Borradori1, J B Caldwell, R A Briggaman, C E Burr, W R Gammon, W D James, K B Yancey.   

Abstract

BACKGROUND: Epidermolysis bullosa acquisita is a subepidermal bullous disease characterized by IgG autoantibodies directed against type VII collagen in anchoring fibrils. These autoantibodies are believed to play an important role in the pathogenesis of sub-lamina densa blister formation in this disease. OBSERVATIONS: We describe a patient with epidermolysis bullosa acquisita who has developed mutilating acral involvement with early syndactyly and extensive scarring lesions of the scalp. The patient's serum contains IgG autoantibodies that bind the dermal side of 1-mol/L sodium chloride-separated human skin (at a titer up to 5120), as determined by indirect immunofluorescence microscopy, and type VII collagen, as determined by immunoblot. The severity of this patient's disease and the height of his immune response to type VII collagen prompted us to assess the pathogenicity of his autoantibodies in a murine model. Purified IgG from our patient (or that from a healthy volunteer who served as a control) was administered subcutaneously to BALB/c mice (10 mg/g of body weight) on 2 consecutive days. Light microscopy of normal-appearing skin showed pronounced dermal edema and a dense granulocyte-rich infiltrate in the superficial dermis. Deposits of human IgG, murine C3, and the membrane attack complex of complement were found in the epidermal basement membrane of all experimental mice. Immunogold electron microscopy demonstrated that deposits of human IgG in an experimental subject were localized to anchoring fibrils. Serum samples from mice receiving IgG antibodies from our patient had high titers of circulating antibodies directed against the dermal side of 1-mol/L sodium chloride-separated human skin (titer, 640 to 1280). Light, immunofluorescence, and immunogold electron microscopic studies did not detect such specific alterations in any control mice.
CONCLUSIONS: Acquired autoimmunity to type VII collagen in patients with epidermolysis bullosa acquisita may result in a clinical phenotype closely resembling that observed in patients with dystrophic epidermolysis bullosa. Passive transfer of purified IgG autoantibodies from a patient with severe epidermolysis bullosa acquisita to BALB/c mice produces histologic and immunopathologic alterations consistent with those seen in patients with this disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7741548

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  7 in total

Review 1.  [Bullous autoimmune dermatoses. 2: Pathogenesis].

Authors:  M Hertl; G Schuler
Journal:  Hautarzt       Date:  2002-04       Impact factor: 0.751

2.  Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.

Authors:  Cassian Sitaru; Sidonia Mihai; Christoph Otto; Mircea T Chiriac; Ingrid Hausser; Barbara Dotterweich; Hitoshi Saito; Christian Rose; Akira Ishiko; Detlef Zillikens
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

3.  Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin.

Authors:  Cassian Sitaru; Arno Kromminga; Takashi Hashimoto; Eva B Bröcker; Detlef Zillikens
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

4.  Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice.

Authors:  Z Lazarova; C Yee; T Darling; R A Briggaman; K B Yancey
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

5.  Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus.

Authors:  Noritaka Oyama; Ien Chan; Sallie M Neill; Andrew P South; Fenella Wojnarowska; Yoshio Kawakami; David D'Cruz; Kirti Mepani; Graham J Hughes; Balbir S Bhogal; Fumio Kaneko; Martin M Black; John A McGrath
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

6.  Population-based estimates of humoral autoimmunity from the U.S. National Health and Nutrition Examination Surveys, 1960-2014.

Authors:  Charles F Dillon; Michael H Weisman; Frederick W Miller
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

7.  Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice.

Authors:  Sidonia Mihai; Misa Hirose; Yi Wang; Joshua M Thurman; V Michael Holers; B Paul Morgan; Jörg Köhl; Detlef Zillikens; Ralf J Ludwig; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2018-03-16       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.